Delisting of HLA antigens as a possible strategy to enable transplantation in highly sensitized patients with a cPRA >/= 99.9. Cozzi E. Kidney Int 2025;108:748-751.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Cozzi E. Delisting of HLA antigens as a possible strategy to enable transplantation in highly sensitized patients with a cPRA >/= 99.9. Kidney Int 2025;108:748-751.
PMID: 41110889